Collective unconscious: How gut microbes shape human behavior

Journal of Psychiatric Research

Volumn 63, Issue , 2015, Pages 1-9

  Dinan, Timothy G ^a,b   Stilling, Roman M ^a,b   Stanton, Catherine ^a,b,c   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC   (Ireland)

Author keywords

Autism; Gut brain axis; Microbiome; Microbiota; Psychobiotics; Social behavior

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROBIOTIC AGENT;

AUTISM; BACTEROIDES FRAGILIS; BEHAVIOR; BRAIN; BRAIN DEVELOPMENT; COGNITION; EGO DEVELOPMENT; HUMAN; INTESTINE FLORA; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIAL INTERACTION; STRESS MANAGEMENT; VAGUS NERVE; GASTROINTESTINAL TRACT; MENTAL HEALTH; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BEHAVIOR; BRAIN; GASTROINTESTINAL TRACT; HUMANS; MENTAL HEALTH; MICROBIOTA;

EID: 84926409252     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.02.021     Document Type: Review

References (77)

1. Alex S., Lange K., Amolo T., Grinstead J.S., Haakonsson A.K., Szalowska E., et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor gamma. Mol Cell Biol 2013, 33:1303-1316.
2. Allen G.E. The social and economic origins of genetic determinism: a case history of the American Eugenics Movement, 1900-1940 and its lessons for today. Genetica 1997, 99:77-88.
3. Armougom F., Raoult D. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 2008, 9:576.
4. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
5. Asemi Z., Khorrami-Rad A., Alizadeh S.A., Shakeri H., Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014, 33:198-203.
6. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal I., Centers for Disease C.& Prevention Prevalence of autism spectrum disorders-Autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ 2012, 61:1-19.
7. Bercik P., Collins S.M., Verdu E.F. Microbes and the gut-brain axis. Neurogastroenterol Motil 2012, 24:405-413.
8. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609. 609 e1-3.
9. Boeckxstaens G. The clinical importance of the anti-inflammatory vagovagal reflex. Handb Clin Neurol 2013, 117:119-134.
10. Bregman N.J., Mcallister H.A. Constraints on the Yerkes-Dodson law in skin temperature biofeedback. Int J Neurosci 1983, 21:183-189.
11. Cao X., Lin P., Jiang P., Li C. Characteristics of the gastrointestinal microbiome in children with autism spectrum disorder: a systematic review. Shanghai Arch Psychiatry 2013, 25:342-353.
12. Cecchini D.A., Laville E., Laguerre S., Robe P., Leclerc M., Dore J., et al. Functional metagenomics reveals novel pathways of prebiotic breakdown by human gut bacteria. PLoS One 2013, 8:e72766.
13. Chen X., D'souza R., Hong S.T. The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell 2013, 4:403-414.
14. Claes I.J., Lebeer S., Shen C., Verhoeven T.L., Dilissen E., De Hertogh G., et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol 2010, 162:306-314.
15. Claesson M.J., Cusack S., O'sullivan O., Greene-diniz R., De Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011, 108(Suppl.1):4586-4591.
16. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
17. Clarke G., Cryan J.F., Dinan T.G., Quigley E.M. Review article: probiotics for the treatment of irritable bowel syndrome-focus on lactic acid bacteria. Aliment Pharmacol Ther 2012, 35:403-413.
18. Clarke G., Grenham S., Scully P., Fitzgerald P., Moloney R.D., Shanahan F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013, 18:666-673.
19. Clarke G., Mckernan D.P., Gaszner G., Quigley E.M., Cryan J.F., Dinan T.G. Adistinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome. Front Pharmacol 2012, 3:90.
20. Collins A.L., Kim Y., Sklar P., International Schizophrenia C., O'donovan M.C., Sullivan P.F. Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. Psychol Med 2012, 42:607-616.
21. Collins S.M., Kassam Z., Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 2013, 16:240-245.
22. Couillin P., Le Guern E., Vignal A., Fizames C., Ravise N., Delportes D., et al. Assignment of 112 microsatellite markers to 23 chromosome 11 subregions delineated by somatic hybrids: comparison with the genetic map. Genomics 1994, 21:379-387.
23. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13:701-712.
24. De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014, 156:84-96.
25. De Theije C.G.M., Wopereis H., Ramadan M., van Eijndthoven T., Lambert J., Knol J., et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 2013 Dec 11.
26. Desbonnet L., Clarke G., Shanahan F., Dinan T.G., Cryan J.F. Microbiota is essential for social development in the mouse. Mol Psychiatry 2014, 19:146-148.
27. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. JPsychiatr Res 2008, 43:164-174.
28. Dinan T.G., Cryan J.F. Melancholic microbes: a link between gut microbiota and depression?. Neurogastroenterol Motil 2013, 25:713-719.
29. Dinan T.G., Stanton C., Cryan J.F. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013, 74:720-726.
30. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107:11971-11975.
31. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
32. Faa G., Gerosa C., Fanni D., Nemolato S., Van Eyken P., Fanos V. Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. JMatern Fetal Neonatal Med 2013, 26(Suppl.2):35-43.
33. Foster J.A., Mcvey Neufeld K.A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013, 36:305-312.
34. Funkhouser L.J., Bordenstein S.R. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 2013, 11:e1001631.
35. Gareau M.G., Wine E., Rodrigues D.M., Cho J.H., Whary M.T., Philpott D.J., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
36. Geurts L., Neyrinck A.M., Delzenne N.M., Knauf C., Cani P.D. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2013, 1-15.
37. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front Physiol 2011, 2:94.
38. Hamady M., Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 2009, 19:1141-1152.
39. Hampel H., Prvulovic D., Teipel S., Jessen F., Luckhaus C., Frolich L., et al. The future of Alzheimer's disease: the next 10 years. Prog Neurobiol 2011, 95:718-728.
40. Hsiao E.Y., Mcbride S.W., Hsien S., Sharon G., Hyde E.R., Mccue T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155:1451-1463.
41. Hueston C.M., Deak T. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis. Physiol Behav 2014, 124:77-91.
42. Khanna S., Tosh P.K. Aclinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc 2014, 89:107-114.
43. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl.1):4578-4585.
44. Lobo C., Moreno-Ventas X., Tapia-Paniagua S., Rodriguez C., Morinigo M.A., De La Banda I.G. Dietary probiotic supplementation (Shewanella putrefaciens Pdp11) modulates gut microbiota and promotes growth and condition in Senegalese sole larviculture. Fish Physiol Biochem 2014, 40:295-309.
45. Lombardo M.P. Access to mutualistic endosymbiotic microbes: an underappreciated benefit of group living. Behav Ecol Sociobiol 2008, 62:479-497.
46. Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 2011, 33:574-581.
47. Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 2013, 9:e1003726.
48. Marques T.M., Wall R., Ross R.P., Fitzgerald G.F., Ryan C.A., Stanton C. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 2010, 21:149-156.
49. Martins-De-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. JPsychiatr Res 2010, 44:149-156.
50. Matsumoto M., Kibe R., Ooga T., Aiba Y., Sawaki E., Koga Y., et al. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 2013, 7:9.
51. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011, 12:453-466.
52. McFall-Ngai M., Hadfield M.G., Bosch T.C., Carey H.V., Domazet-Loso T., Douglas A.E., et al. Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci U. S. A 2013, 110:3229-3236.
53. Mcvey Neufeld K.A., Mao Y.K., Bienenstock J., Foster J.A., Kunze W.A. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol Motil off J Eur Gastrointest Motil Soc 2013, 25. 183-e88.
54. Messaoudi M., Violle N., Bisson J.-F., Desor D., Javelot H., Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011 Aug, 2(4):256-261.
55. Montiel-Castro A.J., Gonzalez-Cervantes R.M., Bravo-Ruiseco G., Pacheco-Lopez G. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci 2013, 7:70.
56. Neufeld K.M., Kang N., Bienenstock J., Foster J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011, 23:255-264. e119.
57. Nicodemus K.K., Elvevag B., Foltz P.W., Rosenstein M., Diaz-Asper C., Weinberger D.R. Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach. Cortex J Devoted Study Nerv Syst Behav 2014, 55:182-191.
58. O'sullivan E., Barrett E., Grenham S., Fitzgerald P., Stanton C., Ross R.P., et al. BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels?. Benef Microbes 2011, 2:199-207.
59. Palmer C., Bik E.M., Digiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
60. Park D.Y., Ahn Y.T., Park S.H., Huh C.S., Yoo S.R., Yu R., et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 2013, 8:e59470.
61. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. Ahuman gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
62. Ramakrishna B.S. Role of the gut microbiota in human nutrition and metabolism. JGastroenterol Hepatol 2013, 28(Suppl.4):9-17.
63. Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuquoy L., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007, 13:35-37.
64. Russell W.R., Hoyles L., Flint H.J., Dumas M.E. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013, 16:246-254.
65. Sainio E.L. The role of adrenal hormones in the activation of tryptophan 2,3-dioxygenase by nicotinic acid in rat liver. Methods Find Exp Clin Pharmacol 1997, 19:465-470.
66. Savignac H.M., Corona G., Mills H., Chen L., Spencer J.P., Tzortzis G., et al. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem Int 2013, 63:756-764.
67. Schmidt K., Cowen P.J., Harmer C.J., Tzortzis G., Errington S., Burnet P.W. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacol Berl 2014.
68. Shanahan F. The gut microbiota-a clinical perspective on lessons learned. Nat Rev Gastroenterol Hepatol 2012, 9:609-614.
69. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. JPhysiol 2004, 558:263-275.
70. Tan J., Mckenzie C., Potamitis M., Thorburn A.N., Mackay C.R., Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol 2014, 121:91-119.
71. Tania M., Khan M.A., Xia K. Recent advances in animal model experimentation in autism research. Acta Neuropsychiatr 2014, 26:264-271.
72. Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144:1394-1401. 1401 e1-4.
73. Troyer K. Microbes, herbivory and the evolution of social-behavior. JTheor Biol 1984, 106:157-169.
74. Viswanathan J., Haapasalo A., Kurkinen K.M., Natunen T., Makinen P., Bertram L., et al. Ubiquilin-1 modulates gamma-secretase-mediated epsilon-site cleavage in neuronal cells. Biochem 2013, 52:3899-3912.
75. Wall R., Marques T.M., O'sullivan O., Ross R.P., Shanahan F., Quigley E.M., et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012, 95:1278-1287.
76. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009, 106:3698-3703.
77. Zhou L., Chen H., Wen Q., Zhang Y. Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012, 24:695-701.